The effects of adiponectin and leptin on human endothelial cell proliferation: A live-cell study

Journal of Vascular Research

Volumn 49, Issue 2, 2012, Pages 111-122

  Álvarez, Granada ^a   Visitacion Bartolome M ^a   Miana, María ^a   Jurado López, Raquel ^a   Martín, Ruben ^c   Zuluaga, Pilar ^b   Martinez Martinez, Ernesto ^a   Nieto, M Luisa ^c   Alvarez Sala, Luis A ^a   Millán, Jesús ^a   Lahera, Vicente ^a   Cachofeiro, Victoria ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b SCHOOL OF MEDICINE   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Adiponectin; Endothelial cells; Leptin; Live cell image technique; Proliferation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ADIPONECTIN; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ARTICLE; CELL DEATH; CELL FUNCTION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; FETAL BOVINE SERUM; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROVASCULAR ENDOTHELIAL CELL; MITOSIS; PRIORITY JOURNAL; SERUM; SIGNAL TRANSDUCTION;

ADIPONECTIN; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CHROMONES; ENDOTHELIUM, VASCULAR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; HUMANS; LEPTIN; MICROCIRCULATION; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES;

EID: 84863394792     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000332332     Document Type: Article

References (47)

1. Sabin MA, Shield JP: Childhood obesity. Front Horm Res 2008; 36: 85-96.
2. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH: American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: a 1997 update. Circulation 2006; 113: 898-918.
3. Caterson ID, Hubbard V, Bray GA, Grunstein R, Hansen BC, Hong Y, Labarthe D, Seidell JC, Smith SC Jr: Prevention Conference VII: obesity, a worldwide epidemic related to heart disease and stroke: group III: worldwide comorbidities of obesity. Circulation 2004; 110:e476-e483.
4. Bray GA: Medical consequences of obesity. J Clin Endocrinol Metab 2004; 89: 2583-2589.
5. Thalmann S, Méier CA: Local adipose tissue depots as cardiovascular risk factors. Cardiovasc Res 2007; 75: 690-701. (Pubitemid 47238732)
6. Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840-844.
7. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T: Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678. (Pubitemid 33108132)
8. Rueda-Clausen CF, López-Jaramillo P, Luengas C, Oubiña MP, Cachofeiro V, Lahera V: Inflammation but not endothelial dysfunction is associated with the severity of coronary artery disease in dyslipidemic subjects. Mediators Inflamm 2009; 2009: 469169.
9. Galic S, Oakhill JS, Steinberg GR: Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010; 316: 129-139.
10. Lau DCW, Dhillon B, Yan H, Szmitko PE, Verma S: Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart 2005; 288:H2031-H2041. (Pubitemid 40604084)
11. Matsubara M, Maruoka S, Katayose S: Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002; 147: 173-180.
12. Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerich RL, Meneilly GS, Egan JS, Elahi D: Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 2003; 26: 2383-2388. (Pubitemid 36993330)
13. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599. (Pubitemid 30353893)
14. Tsao TS, Lodish HF, Fruebis J: ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol 2002; 440: 213- 221.
15. Im JA, Kim SH, Lee JW, Shim JY, Lee HR, Lee DC: Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults. Metabolism 2006; 55: 1546-1550.
16. Cheng KK, Lam KS, Wang Y, Huang Y, Carling D, Wu D, Wong C, Xu A: Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes 2007; 56: 1387-1394. (Pubitemid 46715600)
17. Motoshima H, Wu X, Mahadev K, Golstein BJ: Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun 2004; 315: 264-271. (Pubitemid 38183103)
18. Shin JH, Kim JH, Lee WY, Shim JY: The expression of adiponectin receptors and the effects of adiponectin and leptin on airway smooth muscle cells. Yonsei Med J 2008; 49: 804-810.
19. Zhu W, Cheng KK, Vanhoutte PM, Lam KS, Xu A: Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond) 2008; 114: 361-374. (Pubitemid 351397385)
20. Kadowaki T, Yamauchi T: Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439-451. (Pubitemid 40686653)
21. Könner AC, Klöckener T, Brüning JC: Control of energy homeostasis by insulin and leptin: targeting the arcuate nucleus and beyond. Physiol Behav 2009; 97: 632-638.
22. Martin SS, Qasim A, Reilly MP: Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 2008; 52: 1201-1210.
23. Beltowski J: Leptin and atherosclerosis. Atherosclerosis 2006; 189: 47-60.
24. Fantuzzi G, Mazzone T: Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol 2007; 27: 996- 1003.
25. Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C: Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res 2005; 126: 121-129. (Pubitemid 40726256)
26. Anjum R and Blenis J: The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 2008; 9: 747-758.
27. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T, Walsh K: Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 2004; 279: 1304-1309. (Pubitemid 38082655)
28. Martín-Fernández B, de las Heras N, Miana M, Ballesteros S, Delgado C, Song S, Hintze T, Cachofeiro V, Lahera V: Structural, functional, and molecular alterations produced by aldosterone plus salt in rat heart: association with enhanced serum and glucocorticoid- regulated kinase-1 expression. J Cardiovasc Pharmacol 2011; 57: 114-121.
29. Miana M, de Las Heras N, Rodriguez C, Sanz-Rosa D, Martin-Fernandez B, Mezzano S, Lahera V, Martinez-Gonzalez J, Cachofeiro V: Effect of eplerenone on hypertension- associated renal damage in rats: potential role of peroxisome proliferator activated receptor gamma (PPAR-γ). J Physiol Pharmacol 2011; 62: 87-94.
30. Wolk R, Deb A, Caplice NM, Somers VK: Leptin receptor and functional effects of leptin in human endothelial progenitor cells. Atherosclerosis 2005; 183: 131-139. (Pubitemid 41416831)
31. Shibata R, Ouchi N, Kihara S, Sato K, Funahashi T, Walsh K: Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of AMP-activated protein kinase signaling. J Biol Chem 2004; 279: 28670-28674. (Pubitemid 38900150)
32. Bråkenhielm E, Veitonmäki N, Cao R, Kihara S, Matsuzawa Y, Zhivotocsky B, Funahashi T, Cão Y: Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA 2004; 101: 2476- 2481.
33. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF: Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001; 98: 2005-2010. (Pubitemid 32165613)
34. Tomizawa A, Hattori Y, Kasai K, Nakano Y: Adiponectin induces NF-kappaB activation that leads to suppression of cytokine-induced NF-kappaB activation in vascular endothelial cells: globular adiponectin versus high molecular weight adiponectin. Diab Vasc Dis Res 2008; 5: 123-127. (Pubitemid 351839284)
35. Matsuda M, Shimomura I, Sata, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, Matsuzawa Y: Role of adiponectin in preventing vascular stenosis: the missing link of adipo-vascular axis. J Biol Chem 2002; 277: 37487-37491.
36. Kobayashi H, Ouchi N, Kihara S, Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, Matsuzawa Y: Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004; 94:e27-e31.
37. Lin LY, Lin CY, Su TC, Liau CS: Angiotensin II-induced apoptosis in human endothelial cells is inhibited by adiponectin through restoration of the association between endothelial nitric oxide synthase and heat shock protein 90. FEBS Lett 2004; 574: 106-110.
38. Mahadev K, Wu X, Donnelly S, Ouedraogo R, Eckhart AD, Goldstein BJ: Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells. Cardiovasc Res 2008; 78: 376-384. (Pubitemid 351556105)
39. Artwohl M, Roden M, Hölzenbein T, Freudenthaler A, Waldhäusl W, Baumgartner-Parzer SM: Modulation by leptin of proliferation and apoptosis in vascular endothelial cells. Int J Obes Relat Metab Disord 2002; 26: 577- 580.
40. Chen Z, Liu F, Ren Q, Zhao Q, Ren H, Lu S, Zhang L, Han Z: Hemangiopoietin promotes endothelial cell proliferation through PI-3K/ Akt pathway. Cell Physiol Biochem 2008; 22: 307-314.
41. Grehan JF, Levay-Young B.K, Fogelson J.L, François-Bogarçon V, Benson BA, Dalmasso AP: IL-4 and IL-13 induce protection of porcine endothelial cells from killing by human complement and from apoptosis through activation of a phosphatidylinositide 3-kinase/ Akt pathway. J Immunol 2005; 175: 1903- 1910.
42. Kim HH, Shin HS, Kwak HJ, Ahn KY, Kim JH, Lee HJ, Lee MS, Lee ZH, Koh GY: RANKL regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/ Akt signal transduction pathway. FASEB J 2003; 17: 2163-2165.
43. Lee M, Klein RL, El-Shewy H.M, Luttrell DK, Luttrell LM: The adiponectin receptors adipoR1 and adipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth. Biochemistry 2008; 47: 11682-11692.
44. Tomizawa A, Hattori Y and Kasai K: Induction of gene expression in response to globular adiponectin in vascular endothelial cells. Life Sci 2009; 85: 457-461.
45. Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG: Dimerization of adiponectin receptor 1 is inhibited by adiponectin. J Cell Sci 2010; 123: 1320-1328.
46. Wolk R, Deb A, Caplice NM, Somers VK: Leptin receptor and functional effects of leptin in human endothelial progenitor cells. Atherosclerosis 2005; 183: 131-139. (Pubitemid 41416831)
47. Chen JX, Stinnett A: Critical role of the NADPH oxidase subunit p47phox on vascular TLR expression and neointimal lesion formation in high-fat diet-induced obesity. Lab Invest 2008; 88: 1316-1328.